Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | F3Y25 | — |
Expired dose administered.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 2-year-old male patient who received HAV (Havrix) (batch number F3Y25, expiry date 15-FEB-2025) for prophylaxis. On 10-JUL-2025, the patient received Havrix. On 10-JUL-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered.). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-JUL-2025 The nurse practitioner called to inform that a medical assistant used a dose of Havrix and that it was expired and administered to a patient. According to reporter, dose had expired on 15th February 2025 and was administered on 10th July 2025 which led to expired vaccine used. The reporter mentioned that the expired dose was administered to two twins. The vaccine administration facility was the same as primary reporter.